top of page
gradientForSurfBreak.png

Item List

​
PR Newswire
Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and announced strategic cost cuts, which will include a workforce reduction and other operating expense reductions.

Recent Posts

Portfolio Company

Carlsmed.png

AI Used for Skin Cancer Checks at London Hospital
...

BBC

​

View More

Portfolio Company

Carlsmed.png

CARTI Cancer Center Deploys DeepScribe's Ambient Operating System for Oncology ...

PR Newswire

​

View More

Portfolio Company

Carlsmed.png

Ideem locks in $2.4M seed round for trust tech spinout driven by Toby Rush, star ...

Startland News

​

View More
surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page